Trial intelligence / Profile preview

Open-label comparative study of sirolimus vs mycophenolate mofetil in de novo renal transplant recipients on cyclosporine and corticosteroids

2014-004102-15Phase 4

Sponsor
Wyeth
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sirolimus in kidney transplant (2 arms), sponsored by Wyeth. Primary endpoint: Incidence of Efficacy Failure.

02

Drugs

sirolimus
03

Conditions

kidney transplant

Beyond the preview

Go deeper on 2014-004102-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004102-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call